http://www.clinicaltrialsarena.com/news/alnylams-kardia-1-trial-meets-primary-endpoint-in-hypertension/
0
0
11/14/23 at 3:12pm
Organization
Clinical Trials Arena
Author
Joshua Silverwood
32 words
0
Comments
Alnylam has announced positive results from its Phase II study of zilebesiran for the treatment of patients with hypertension.
You are the first to view
Create an account
or login to join the discussion